| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 03/11/2004 | US20040049053 Reacting 4-hydroxycoumarin with hydroxylamine in the presence of a base; sulfonating product to form salt of the methanesulfonic acid; forming benzisoxazolemethanesulfonamide from either the acetic acid or methanesulfonic acid |
| 03/11/2004 | US20040048908 E.g., 3-(5-(3,4-dichlorophenyl)- 4-isoxazolyl)propan-1-ol; prophylaxis or treatment of diabetes, impaired glucose tolerance or diabetic complications |
| 03/11/2004 | US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048316 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703348 Heterocyclyl-substituted benzoylcyclohexandiones, their preparation, and their use as herbicides |
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018410A1 Substituted benzanilide compound and pest control agent |
| 03/04/2004 | US20040044062 Method of treatment of viral infection including HIV using water soluble fullerenes - III |
| 03/04/2004 | US20040044052 N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699996 Production method of isoxazolidinedione compound |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699884 Antiinflammatory cyclooxygenase inhibitors. |
| 02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2003039549A8 Selective antibacterial agents |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1139580C Substituted benzylamines and their use for treatment of depression |
| 02/25/2004 | CN1139579C Isoxazolecarboxamide derivatives |
| 02/25/2004 | CN1139578C Preparation of isoxazoline-3-yl-acyl benzene |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | CA2065983C Crop-protecting compositions containing isoxazolines or isothiazolines, novel isoxazolines and isothiazolines, and their preparation |
| 02/19/2004 | WO2004014879A1 New process |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014370A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2003004147A8 Compound libraries |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034081 Estrogen receptor modulators |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040033994 Use of compounds comprising a nitrogen-oxygen heterocycle |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2495120A1 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | CA2495067A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/18/2004 | CN1138764C Isoxazole derivatives |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693124 3h-1,2,4-triazol-3-one or 3h-isooxazol-3-one derivatives; efficient fungicidal activity |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/12/2004 | WO2003096979A3 Drug therapy for celiac sprue |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029941 Zonisamide use in obesity and eating disorders |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/11/2004 | EP1387831A1 Substituted arylketones |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP0901479B1 Isoxazole derivatives and their use as herbicides |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/05/2004 | WO2004011448A1 Therapeutic compounds for treating dyslipidemic conditions |
| 02/05/2004 | WO2004011444A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024038 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP0992503B1 Process for producing isooxazolidinedione compound |
| 02/03/2004 | US6686493 Antiproliferation agent; antiinflammatory agents; side effect reduction |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/28/2004 | EP1384722A1 Process for the production of 2-(5-methyl-4-oxazolyl)acetates |